Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDADMA Biologics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.05 | $0.06 | $0.06 |
| Q2 2024 | 1 | $0.07 | $0.09 | $0.08 |
| Q3 2024 | 1 | $0.12 | $0.14 | $0.13 |
| Q4 2024 | 3 | $0.14 | $0.17 | $0.16 |
| Q1 2025 | 2 | $0.13 | $0.18 | $0.16 |
| Q2 2025 | 1 | $0.16 | $0.18 | $0.17 |
| Q3 2025 | 1 | $0.18 | $0.20 | $0.19 |
| Q4 2025 | 1 | $0.19 | $0.22 | $0.21 |
ADMA Biologics, Inc. Earnings Date And Information
ADMA Biologics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.13 by $0.02. The company had revenue of 119.84 M for the quarter and had revenue of 258.21 M for the year. ADMA Biologics, Inc. has generated $0 earnings per share over the last year ($-0.13 diluted earnings per share) and currently has a price-to-earnings ratio of 59.91. ADMA Biologics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
ADMA Biologics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | $0.13 | $0.15 | 0.02 | $105.81 M | $119.84 M |
| 08/08/2024 | Q2 2024 | $0.08 | $0.14 | 0.06 | $86.43 M | $107.19 M |
| 05/09/2024 | Q1 2024 | $0.06 | $0.08 | 0.02 | $81.88 M | |
| 02/28/2024 | Q4 2023 | -$0.01 | -$0.08 | -0.07 | $73.90 M | |
| 11/08/2023 | Q3 2023 | $0.00 | $0.01 | 0.01 | $62.13 M | $67.27 M |
| 08/09/2023 | Q2 2023 | -$0.02 | -$0.03 | -0.01 | $55.50 M | $60.12 M |
| 05/10/2023 | Q1 2023 | -$0.05 | -$0.06 | -0.01 | $56.91 M | |
| 03/23/2023 | Q4 2022 | -$0.13 | $49.98 M | |||
| 11/09/2022 | Q3 2022 | -$0.08 | -$0.10 | -0.02 | $34.48 M | $41.09 M |
| 08/10/2022 | Q2 2022 | -$0.09 | -$0.07 | 0.02 | $31.81 M | $33.91 M |
| 05/11/2022 | Q1 2022 | -$0.08 | -$0.18 | -0.1 | $29.10 M | |
| 03/24/2022 | Q4 2021 | -$0.09 | $26.38 M | |||
| 11/10/2021 | Q3 2021 | -$0.15 | -$0.13 | 0.02 | $18.70 M | $20.68 M |
| 08/11/2021 | Q2 2021 | -$0.15 | -$0.15 | 0 | $16.42 M | $17.83 M |
| 05/12/2021 | Q1 2021 | -$0.17 | -$0.16 | 0.01 | $16.05 M | |
| 03/25/2021 | Q4 2020 | -$0.20 | $13.96 M | |||
| 11/05/2020 | Q3 2020 | -$0.21 | -$0.19 | 0.02 | $9.96 M | $10.28 M |
| 08/05/2020 | Q2 2020 | -$0.19 | -$0.23 | -0.04 | $10.57 M | $7.79 M |
| 05/06/2020 | Q1 2020 | -$0.13 | -$0.26 | -0.13 | $10.20 M | |
| 03/12/2020 | Q4 2019 | -$0.18 | $12.04 M |
ADMA Biologics, Inc. Earnings: FAQ's
When is ADMA Biologics, Inc.'s earnings date?
ADMA Biologics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
Did ADMA Biologics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, ADMA Biologics, Inc. (:ADMA) reported $0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $0.13 by $0.02.
How can I listen to ADMA Biologics, Inc.'s earnings conference
call?
The conference call for ADMA Biologics, Inc.'s latest earnings report can be listened to online.
How can I read ADMA Biologics, Inc.'s conference call transcript?
The conference call transcript for ADMA Biologics, Inc.'s latest earnings report can be read online.
How much revenue does ADMA Biologics, Inc. generate each year?
ADMA Biologics, Inc. (:ADMA) has a recorded annual revenue of $258.21 M.
How much profit does ADMA Biologics, Inc. generate each year?
ADMA Biologics, Inc. (:ADMA) has a recorded net income of $258.21 M. ADMA Biologics, Inc. has generated $-0.13 earnings per share over the last four quarters.
What is ADMA Biologics, Inc.'s price-to-earnings ratio?
ADMA Biologics, Inc. (:ADMA) has a price-to-earnings ratio of 59.91 and price/earnings-to-growth ratio is 0.64.